These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8527002)

  • 21. Axial hypertonicity in Parkinson's disease: direct measurements of trunk and hip torque.
    Wright WG; Gurfinkel VS; Nutt J; Horak FB; Cordo PJ
    Exp Neurol; 2007 Nov; 208(1):38-46. PubMed ID: 17692315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
    Ramaker C; Hilten JJ
    Cochrane Database Syst Rev; 2002; (2):CD003634. PubMed ID: 12076493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait.
    Xie J; Krack P; Benabid AL; Pollak P
    J Neurol; 2001 Dec; 248(12):1068-72. PubMed ID: 12013584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
    Tarsy D; Scollins L; Corapi K; O'Herron S; Apetauerova D; Norregaard T
    Stereotact Funct Neurosurg; 2005; 83(5-6):222-7. PubMed ID: 16534254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.
    Growdon JH; Kieburtz K; McDermott MP; Panisset M; Friedman JH
    Neurology; 1998 May; 50(5):1327-31. PubMed ID: 9595982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Subacute worsening of rigidity in a patient with Parkinson disease].
    Bekkelund SI; Lilleng H; Arntzen KA
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2065-6. PubMed ID: 18853522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levodopa response differs in Parkinson's motor subtypes: A task-based effective connectivity study.
    Mohl B; Berman BD; Shelton E; Tanabe J
    J Comp Neurol; 2017 Jun; 525(9):2192-2201. PubMed ID: 28256710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of rotigotine in elderly patients with Parkinson's disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials.
    Nomoto M; Iwaki H; Kondo H; Sakurai M
    J Neurol; 2018 Feb; 265(2):253-265. PubMed ID: 29164312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ropinirole: a review of its use in the management of Parkinson's disease.
    Matheson AJ; Spencer CM
    Drugs; 2000 Jul; 60(1):115-37. PubMed ID: 10929932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    Stocchi F; Rabey JM
    Eur J Neurol; 2011 Dec; 18(12):1373-8. PubMed ID: 21895884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia.
    Bartels AL; Balash Y; Gurevich T; Schaafsma JD; Hausdorff JM; Giladi N
    J Clin Neurosci; 2003 Sep; 10(5):584-8. PubMed ID: 12948464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
    Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
    Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different patterns of spontaneous brain activity between tremor-dominant and postural instability/gait difficulty subtypes of Parkinson's disease: a resting-state fMRI study.
    Chen HM; Wang ZJ; Fang JP; Gao LY; Ma LY; Wu T; Hou YN; Zhang JR; Feng T
    CNS Neurosci Ther; 2015 Oct; 21(10):855-66. PubMed ID: 26387576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa does not aggravate postural tremor in Parkinson's disease.
    Kulisevsky J; Avila A; Barbanoj M; Antonijoan R; Torres J; Arcelus R
    Clin Neuropharmacol; 1995 Oct; 18(5):435-42. PubMed ID: 8665557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Slowing of high-speed memory scanning in Parkinson's disease is related to the severity of parkinsonian motor symptoms.
    Ransmayr G; Bitschnau W; Schmidhuber-Eiler B; Berger W; Karamat E; Poewe W; Kemmler GW
    J Neural Transm Park Dis Dement Sect; 1990; 2(4):265-75. PubMed ID: 1964055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
    Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
    Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
    Teychenne PF; Bergsrud D; Elton RL; Racy A
    Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease.
    Bastian AJ; Kelly VE; Perlmutter JS; Mink JW
    Mov Disord; 2003 Sep; 18(9):1008-17. PubMed ID: 14502668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
    Cubo E; González M; Aguilar A; Quintana S
    Neurologia; 2006; 21(1):12-8. PubMed ID: 16525921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.